Invention Grant
- Patent Title: CXCR4 receptor-binding compounds useful for increasing interferon level
-
Application No.: US16310149Application Date: 2017-06-16
-
Publication No.: US11433048B2Publication Date: 2022-09-06
- Inventor: Nicolas Pietrancosta , Nikaïa Smith , Jean-Philippe Herbeuval
- Applicant: CENTRE NATIONAL de la RECHERCHE SCIENTIFIQUE , UNIVERSITE PARIS DESCARTES
- Applicant Address: FR Paris; FR Paris
- Assignee: CENTRE NATIONAL de la RECHERCHE SCIENTIFIQUE,UNIVERSITE PARIS DESCARTES
- Current Assignee: CENTRE NATIONAL de la RECHERCHE SCIENTIFIQUE,UNIVERSITE PARIS DESCARTES
- Current Assignee Address: FR Paris; FR Paris
- Agency: Wolter VanDyke Davis PLLC
- Agent Michael Byrne
- Priority: FR16305736.7 20160616
- International Application: PCT/EP2017/064832 WO 20170616
- International Announcement: WO2017/216373 WO 20171221
- Main IPC: A61K31/395
- IPC: A61K31/395 ; A61K31/4725 ; G16C20/64 ; G16B35/20 ; A61K31/4164 ; A61K31/417 ; A61K31/4709 ; G01N33/566 ; G01N33/68
Abstract:
The invention relates to a CXCR4 receptor-binding compound for use for increasing or restoring interferon (IFN) level in an individual, wherein the interferon is a type-I interferon (IFN-I).
Public/Granted literature
- US20190175549A1 CXCR4 RECEPTOR-BINDING COMPOUNDS USEFUL FOR INCREASING INTERFERON LEVEL Public/Granted day:2019-06-13
Information query
